Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Oxford BioMedica encouraged by phase I/II Parkinson’s trial

July 15, 2009 Research and Development Oxford BioMedica, Prosavin

News

Poor antigen yields limiting H1N1 vaccine supplies, says WHO

July 15, 2009 Manufacturing and Production, Research and Development h1n1, vaccines

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …
News

Blueprint to fast track innovative drugs and devices

July 14, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NHS

A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
News

Charles River restructures as president sets retirement date

July 14, 2009 Research and Development CRO, Charles River

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
News

Clinical trials market worth $50bn in 2008

July 14, 2009 Research and Development CRO, strategy

The global clinical trials market topped $50 billion last year and, despite the recent downturn in the fortunes of most …
News

US approval boosts Plavix competitor

July 14, 2009 Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
News

Chiesi breaks ground on new R&D headquarters in Palma

July 13, 2009 Research and Development Chiesi, Europe, Italy

Construction of Chiesi's new 70 million euro centre for research and development has begun in Parma, Italy. The Italian company …
News

Contract research sector: news in brief

July 13, 2009 Research and Development Veeda

Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …
News

Biopharma company contributes to GSK’s ‘patent pool’

July 10, 2009 Research and Development Orphan

Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …
News

WHO gives Cervarix green light for use in developing nations

July 10, 2009 Research and Development, Sales and Marketing Cervarix, vaccines

News

NICE to reconsider GSK’s Tyverb

July 9, 2009 Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …
News

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009 Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …
News

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009 Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
News

Europe launches pharma competition crackdown

July 8, 2009 Research and Development Europe, generics

The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …
News
Eisai's new European HQ in Hatfield, Hertfordshire

Eisai opens new European HQ in the UK

July 8, 2009 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ

Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025